Lead the field

Work with precision at unrivaled speed to make informed decisions backed up by science. To meet the challenges of modern drug discovery, take advantage of BioSolveIT’s detailed and precise results — without compromise. We will address every step of your needs, from start to finish.

Discover with confidence

Profit from our long-standing experience and collaboration history with Fortune 100 pharma companies and academia. Our secure software has been developed and backed by renowned partners - including BAYER, Roche, Merck, BASF, and others. BioSolveIT’s success record is cited in thousands of publications worldwide.
start right away

Start right away

BioSolveIT’s technology is fine-tuned for the needs of the pharma industry, academics, beginners, and veterans alike. Clean and comprehensive user interface removes the need for a learning curve. Easy access fostered by intuitive operation will maximize the likelihood of your success. Simply download the multiplatform software and discover active molecules!
drug discovery evolution

Experience drug discovery

Evolve the way you approach drug design, with the most liberating breakthrough. The stimulating interface creates a dialog between you and your compound where you can see why something is considered good or bad. Clean visualization combined with scientific finesse mold into a fun-to-use drug design experience.

Current news

Meet BioSolveIT at 2023 Conferences
January 17, 2023 16:34 CET
The BioSolveIT Team is excited to announce its conference plans for the first half of 2023. The company will be participating in several events throughout Q1 and Q2, giving attendees the opportunity to meet the team in person and learn more about the latest developments in the company’s software offerings....
Read on
Chemical Space Docking: Odyssey to Unlock Relevant Compounds
Thu, 26 Jan 2023, 16:00 CET
Chemical Space exploration is experiencing a major breakthrough, thanks to rapid advancements in the technology behind it. By seamlessly integrating computational and experimental methods, researchers are now able to unlock the full potential of structure-based drug discovery. One such method that has gained significant attention is Chemical Space Docking, which plays...
Read on
Update: Drugathon 2022 Enters Compound Acquisition Stage!
January 9, 2023 13:53 CET
We are excited to share the latest news on the progress of the first BioSolveIT Drugathon 2022. With the goal to discover novel antibiotics for the target 1-deoxy-d-xylulose 5-phosphate synthase (DXPS), users enjoyed BioSolveIT applications to design and optimize their compounds with thiamine pyrophosphate (TPP) as starting point. Fragments were...
Read on